| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |